Company / Cash & Equivalents
CANNABIS SUISSE CORP. Cash & Equivalents History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$2.9K
FY2025
5-year range
$0 / $28.6K
FY2021-FY2025
Trend
-90.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has fluctuated over the past 7 years, ranging from $0 in FY2022 to $84,181 in FY2019.
Based on SEC 10-K filings.
$2,850 in FY2025.
Improved from $199 to $2,850 over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash & equivalents decreased 90.0% year-over-year.
- Peak cash & equivalents was recorded in FY2019.
- Lowest cash & equivalents in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -4.63 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9K | -90.0% |
| FY2024 | $28.6K | +14252.8% |
| FY2023 | $199 | - |
| FY2022 | $0 | - |
| FY2021 | - | - |
| FY2019 | $84.2K | +1260.6% |
| FY2018 | $6.2K | +0.0% |
| FY2017 | $6.2K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026